Kelesoglu, N. Et Al. 2022. Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , vol.26, no.7 , 392-403.

Kelesoglu, N., Kori, M., TURANLI, B., ARĞA, K. Y., Yilmaz, B., & Duru, O. A., (2022). Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , vol.26, no.7, 392-403.

Kelesoglu, Nurdan Et Al. "Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation," OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , vol.26, no.7, 392-403, 2022

Kelesoglu, Nurdan Et Al. "Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation." OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , vol.26, no.7, pp.392-403, 2022

Kelesoglu, N. Et Al. (2022) . "Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation." OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , vol.26, no.7, pp.392-403.

@article{article, author={Nurdan Kelesoglu Et Al. }, title={Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation}, journal={OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY}, year=2022, pages={392-403} }